M. Javaid

First name
M.
Middle name
K.
Last name
Javaid
Khalid, S., Calderon-Larranaga, S., Sami, A., Hawley, S., Judge, A., Arden, N., et al. (2022). Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. Osteoporos Int. http://doi.org/10.1007/s00198-021-06262-1
Prieto-Alhambra, D., Javaid, M. K., Judge, A., Maskell, J., Kiran, A., de Vries, F., et al. (2011). Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Arthritis Rheum. http://doi.org/10.1002/art.30214
Prieto-Alhambra, D., Javaid, M. K., Maskell, J., Judge, A., Nevitt, M., Cooper, C., & Arden, N. K. (2011). Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study. Ann Rheum Dis. http://doi.org/10.1136/ard.2010.131110
Prieto-Alhambra, D., Javaid, M. K., Judge, A., Murray, D., Carr, A., Cooper, C., & Arden, N. K. (2011). Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. Bmj. http://doi.org/10.1136/bmj.d7222
Culliford, D. J., Maskell, J., Kiran, A., Judge, A., Javaid, M. K., Cooper, C., & Arden, N. K. (2012). The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database. Osteoarthritis Cartilage. http://doi.org/10.1016/j.joca.2012.02.636
Pouwels, S., de Boer, A., Javaid, M. K., Hilton-Jones, D., Verschuuren, J., Cooper, C., et al. (2013). Fracture rate in patients with myasthenia gravis: the general practice research database. Osteoporos Int. http://doi.org/10.1007/s00198-012-1970-5
Prieto-Alhambra, D., Javaid, M. K., Judge, A., Maskell, J., Cooper, C., & Arden, N. K. (2015). Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2013-204043
Hawley, S., Leal, J., Delmestri, A., Prieto-Alhambra, D., Arden, N. K., Cooper, C., et al. (2016). Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis. J Bone Miner Res. http://doi.org/10.1002/jbmr.2882
Shah, A., Prieto-Alhambra, D., Hawley, S., Delmestri, A., Lippett, J., Cooper, C., et al. (2017). Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study. Osteoporos Int. http://doi.org/10.1007/s00198-016-3811-4
Leal, J., Gray, A. M., Hawley, S., Prieto-Alhambra, D., Delmestri, A., Arden, N. K., et al. (2017). Cost-Effectiveness of Orthogeriatric and Fracture Liaison Service Models of Care for Hip Fracture Patients: A Population-Based Study. J Bone Miner Res. http://doi.org/10.1002/jbmr.2995